PAPER Tang X, He Y, Liu J, Xu J, Peng Q
SEARCH RESULTS
4317 RESULTS
PAPER Zheng Y, Yu Z, Cai H, Kou W, Yang C, Li S, Zhang N, Feng T
Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.
Mov Disord. 2024 May 7; PubMed.PAPER Wetering JV, Geut H, Bol JJ, Galis Y, Timmermans E, Twisk JW, Hepp DH, Morella ML, Pihlstrom L, Lemstra AW, Rozemuller AJ, Jonkman LE, van de Berg WD
Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Acta Neuropathol Commun. 2024 May 7;12(1):73. PubMed.PAPER Dada ST, Toprakcioglu Z, Cali MP, Röntgen A, Hardenberg MC, Morris OM, Mrugalla LK, Knowles TP, Vendruscolo M
Pharmacological inhibition of α-synuclein aggregation within liquid condensates.
Nat Commun. 2024 May 7;15(1):3835. PubMed.PAPER Libri I, Silvestri C, Caratozzolo S, Alberici A, Pilotto A, Archetti S, Trainini L, Borroni B, Padovani A, Benussi A
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders.
Neurobiol Aging. 2024 Apr 10;140:33-40. PubMed.PAPER Rekers S, Heine J, Thöne-Otto AI, Finke C
Neuropsychiatric symptoms and metamemory across the life span: psychometric properties of the German Multifactorial Memory Questionnaire (MMQ).
J Neurol. 2024 May 8; PubMed.PAPER Wu XR, Zhu XN, Pan YB, Gu X, Liu XD, Chen S, Zhang Y, Xu TL, Xu NJ, Sun S
Amygdala neuronal dyshomeostasis via 5-HT receptors mediates mood and cognitive defects in Alzheimer's disease.
Aging Cell. 2024 May 8;:e14187. PubMed.PAPER Sumbul-Sekerci B, Velioglu HA, Sekerci A
Diabetes-related clinical and microstructural white matter changes in patients with Alzheimer's disease.
Brain Behav. 2024 May;14(5):e3533. PubMed.PAPER Amini N, Ibn Hach M, Lapauw L, Dupont J, Vercauteren L, Verschueren S, Tournoy J, Gielen E
Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia.
J Cachexia Sarcopenia Muscle. 2024 May 7; PubMed.PAPER Chen T, Pan F, Huang Q, Xie G, Chao X, Wu L, Wang J, Cui L, Sun T, Li M, Wang Y, Guan Y, Zheng X, Ren Z, Guo Y, Wang L, Zhou K, Zhao A, Guo Q, Xie F, Jia W
Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer's disease.
Nat Commun. 2024 May 7;15(1):3796. PubMed.PAPER Wasén C, Beauchamp LC, Vincentini J, Li S, LeServe DS, Gauthier C, Lopes JR, Moreira TG, Ekwudo MN, Yin Z, da Silva P, Krishnan RK, Butovsky O, Cox LM, Weiner HL
Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer's disease mouse models.
Nat Commun. 2024 May 8;15(1):3872. PubMed.PAPER Volkmer A, Copland DA, Henry ML, Warren JD, Varley R, Wallace SJ, Hardy CJ
COS-PPA: protocol to develop a core outcome set for primary progressive aphasia.
BMJ Open. 2024 May 6;14(5):e078714. PubMed.PAPER Shoup D, Priola SA
Grp78 destabilization of infectious prions is strain specific and modified by multiple factors including accessory chaperones and pH.
J Biol Chem. 2024 May 6;:107346. PubMed.PAPER Sun Y, Liu C, He L
Adenosine A2A receptor antagonist SCH58261 improves the cognitive function in Alzheimer's disease model mice through activation of Nrf2 via an autophagy-dependent pathway.
Antioxid Redox Signal. 2024 May 8; PubMed.PAPER Valletta M, Vetrano DL, Rizzuto D, Winblad B, Canevelli M, Andersson S, Dale M, Fredolini C, Fratiglioni L, Grande G